32407-11-7

Basic information

• Product Name: 4-methoxy-3,5-dimethylbenzenamine
• Synonyms: 3,5-dichloro-4-methoxybenzenamine
• CAS NO: 32407-11-7
• Molecular Formula: C₇H₇Cl₂NO
• Molecular Weight: 151.20562
• Mol File: 32407-11-7.mol
• Article Data: 7

Chemical Properties

• Melting Point: 80-80.5 °C
• Boiling Point: 128 °C(Press: 4 Torr)
• Appearance: /
• Density: 1.375±0.06 g/cm3(Predicted)
• PKA: 3.08±0.10(Predicted)
• CAS DataBase Reference: 4-methoxy-3,5-dimethylbenzenamine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-methoxy-3,5-dimethylbenzenamine(32407-11-7)
• EPA Substance Registry System: 4-methoxy-3,5-dimethylbenzenamine(32407-11-7)

Safety Data

• Hazardous Substances Data: 32407-11-7(Hazardous Substances Data)

Usage

General Description

4-methoxy-3,5-dimethylbenzenamine, also known as 3,5-dimethyl-4-methoxyaniline, is an organic compound with the chemical formula C9H13NO. It is a substituted aniline, which is a type of aromatic amine. 4-methoxy-3,5-dimethylbenzenamine is commonly used as an intermediate in the synthesis of dyes, pharmaceuticals, and other organic compounds. Its chemical structure consists of a benzene ring with a methoxy group (OCH3) and two methyl groups (CH3) attached to different carbon atoms, as well as an amino group (NH2) attached to another carbon atom. 4-methoxy-3,5-dimethylbenzenamine is a colorless to pale yellow liquid or solid, and it is important to handle it with care due to its potential toxicity and skin and eye irritant properties.

Upstream product

• 17742-69-7 2,6-dichloro-4-nitro-anisole 
• 3107-19-5 3,5-dichloro-4-fluoro-nitrobenzene 
• 618-80-4 2,6-dichloro-4-nitrophenol 

Downstream Products

• 70439-96-2 2,3,5,6-tetrachloroanisidine 
• 421766-14-5 2,3,5-trichloroanisidine 
• 128207-16-9 N-(2,3,5-trichloro-4-methoxyphenyl)acetamide 
• 55411-43-3 3',5'-dichloro-2-hydroxy-4'-methoxybenzanilide 

Relevant articles and documents

THYROID HORMONE RECEPTOR AGONISTS

Provided herein are novel thyroid hormone receptor (TR) agonists, e. g., having Formula I, II, or III. Also provided are methods of preparing the novel TR agonists and method of using the novel TR agonists for treating diseases or disorder modulated by TR agonists, such as NAFLD, NASH, diabetes, hyperlipidemia and/or hypercholesterolemia.

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

The invention relates to a compound of Formula (I) or (IA) compositions comprising compounds of Formula (I) or (IA), and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula (I) or (IA) to a patient in need thereof:

INHIBITORS OF ALPHA-L BETA-2 MEDIATED CELL ADHESION

The present invention relates to a compound of formula: (I), or a pharmaceutically acceptable salt thereof.